Instil Bio, Inc.(TIL)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Instil Bio, Inc. (TIL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TIL at 30.0/100 on a 32-signal composite quality model, placing it at rank #2,508 of 2,962 stocks — the bottom half of the AI-ranked universe. TIL scores in the top quartile across revenue growth (96.6). Areas of concern include revenue scale (2.1) and free cash flow (3.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 3.3/100, reflecting ongoing share issuance or stock-based compensation. Top institutional holders of TIL by reported 13-F value include Curative Ventures V, BML Capital Management, Vivo Capital, based on the most recent SEC filings. TIL trades on the Nasdaq exchange and files with the SEC under CIK 1789769. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TIL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Instil Bio, Inc. directly from SEC EDGAR.